The unique combination of technology marks 25 years of industry innovation and expertise, and signals company’s next phase of ...

Cherry, a full-service creative healthcare agency, has appointed Peter Henshaw as Managing Director. Henshaw will be ...

AstraZeneca has entered into an exclusive licence agreement with Dizal Pharmaceutical for Zegfrovy (sunvozertinib), a novel ...

Exonate has appointed Olav Hellebø as Chief Executive Officer (CEO). Hellebø brings extensive business and scientific ...

Boehringer Ingelheim’s Jascayd (nerandomilast) tablets have been granted marketing authorisation by the Medicines and ...

Ipsen is set to acquire Memo Therapeutics in a deal worth more than €700m EUR that is focused on potravitug, a phase 2 ...

Alignment is not proven by whether teams are coordinated, it is proven by whether their combined efforts are sustained ...

Teva Pharmaceutical has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) seeking approval ...

Older trial participants aren’t rejecting digital technology — they’re rejecting poorly designed, inaccessible experiences ...

Vertex Pharmaceuticals has agreed to acquire Crinetics Pharmaceuticals in a deal worth around $10.0bn. Crinetics is a global ...

The UK’s challenge is less about capability and more about how well it aligns with the way global pharma now operates ...